4.7 Article

Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer

Lei Zhang et al.

Review Immunology

Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?

Francois Ghiringhelli et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Oncology

Mechanisms of resistance to immune checkpoint inhibitors

Russell W. Jenkins et al.

BRITISH JOURNAL OF CANCER (2018)

Article Oncology

Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies

Daniela F. Quail et al.

CLINICAL CANCER RESEARCH (2017)

Review Oncology

De-novo and acquired resistance to immune checkpoint targeting

Nicholas L. Syn et al.

LANCET ONCOLOGY (2017)

Article Cell Biology

Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies

Mattia Bonsignori et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Medicine, General & Internal

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

D. T. Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Immunology

Immune cell promotion of metastasis

Takanori Kitamura et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Immunology

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

EY Lin et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2001)